Icosavax receives fast track designation for IVX-A12 vaccine candidate

Icosavax has received fast track designation from the US FDA for its bivalent RSV and hMPV VLP vaccine candidate IVX-A12.

Related Keywords

Niranjan Kanesa Thasan , ,Fast Track ,